Michael L. Corrado - Concepedia

Author

Michael L. Corrado

SUNY Downstate Health Sciences University

Also Known As

M CORRADO, M Corrado, M L Corrado, M. Corrado, M. L. Corrado, M.L. Corrado, MICHAEL L. CORRADO, Michael Corrado, Michael L. Corrado

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

SUNY Downstate Health Sciences University United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)INC Research (United States)Siga Technologies (United States)

About

Michael L. Corrado is an author at SUNY Downstate Health Sciences University specializing in medicine, clinical microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	32	2.2K
2	Health Sciences	10	10	500
3	Social Sciences	1	1	88
4	Allergy	1	1	17
5	Biomedical Engineering	1	1	376

Michael L. Corrado

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Posaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 Cases J.-A. H. van Burik, R S Hare, Howard F. Solomon, Clinical Infectious Diseases Salvage TherapyProbable ZygomycosisCompassionate-use PosaconazoleAntifungal AgentAntifungal Agents	2006	613
Quantitative Culture of Intravenous Catheters and Other Intravascular Inserts Dennis J. Cleri, Michael L. Corrado, Stephen Seligman The Journal of Infectious Diseases Nonquantitative CulturePathogenic MicrobiologyMicrobial DiseaseMedicineQuantitative Cultures	1980	376
Relationship between Fluoroquinolone Area under the Curve:Minimum Inhibitory Concentration Ratio and the Probability of Eradication of the Infecting Pathogen, in Patients with Nosocomial Pneumonia George L. Drusano, Sandra L. Preston, Cynthia L. Fowler, The Journal of Infectious Diseases Second DrugAntimicrobial SusceptibilityGood MicrobiologicalAntibioticsHealth Sciences	2004	235
ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification Robert Jordan, Arthur J. Goff, Annie Frimm, Antimicrobial Agents and Chemotherapy Oral DosagePharmacotherapyAntiviral DrugNonhuman PrimatesTranslational Medicine	2009	133
Levofloxacin Population Pharmacokinetics and Creation of a Demographic Model for Prediction of Individual Drug Clearance in Patients with Serious Community-Acquired Infection Sandra L. Preston, George L. Drusano, Adam L. Berman, Antimicrobial Agents and Chemotherapy	1998	116
Treatment of Gram-Negative Bacillary Meningitis: Role of the New Cephalosporin Antibiotics Charles E. Cherubin, Michael L. Corrado, Satheesh Nair, Clinical Infectious Diseases	1982	99
A Population Pharmacokinetic Analysis of the Penetration of the Prostate by Levofloxacin George L. Drusano, Sandra L. Preston, M. Van Guilder, Antimicrobial Agents and Chemotherapy	2000	94
Once‐Daily, High‐Dose Levofloxacin versus Ticarcillin‐Clavulanate Alone or Followed by Amoxicillin‐Clavulanate for Complicated Skin and Skin‐Structure Infections: A Randomized, Open‐Label Trial Donald R. Graham, David A. Talan, Ronald Lee Nichols, Clinical Infectious Diseases	2002	93
Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid Sheldon H. Landesman, Michael L. Corrado, Charles C. Cherubin, The American Journal of Medicine New Beta-lactamNeurophysiologyMedicineCerebrospinal FluidNeuropharmacology	1980	88
Norfloxacin: Review of safety studies Michael L. Corrado, William E. Struble, C. P. Peter, The American Journal of Medicine Safety StudiesMedicineToxicologyPharmacologyClinical Toxicology	1987	88

Page 1